QCG
WVE icon

Quadrant Capital Group’s Wave Life Sciences WVE Stock Holding History

Quadrant Capital Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,396
Closed -$17.4K – 2613
2026
Q1 		$17.4K Hold
2,396
– – ﹤0.01% 2043
2025
Q4 		$40.7K Hold
2,396
– – ﹤0.01% 1757
2025
Q3 		$17.5K Buy
+2,396
New +$19.4K ﹤0.01% 1995
2025
Q2 		– Sell
-2,396
Closed -$19.4K – 2649
2025
Q1 		$19.4K Hold
2,396
– – ﹤0.01% 2047
2024
Q4 		$29.6K Hold
2,396
– – ﹤0.01% 1703
2024
Q3 		$19.6K Hold
2,396
– – ﹤0.01% 1897
2024
Q2 		$12K Hold
2,396
– – ﹤0.01% 2057
2024
Q1 		$14.8K Buy
+2,396
New +$12K ﹤0.01% 1962
2021
Q3 		– Sell
-30
Closed – – 2674
2021
Q2 		$0 Buy
+30
New +$196 ﹤0.01% 2591

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Quadrant Capital Group's WVE Position: Q2 2026 in Review

Quadrant Capital Group sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 2,396 shares — an estimated $17.4K sold.

Quadrant Capital Group first reported a position in WVE in Q2 2021 and held it in 9 quarters. The position peaked at $40.7K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Quadrant Capital Group reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 2,396 Wave Life Sciences shares in Q2 2026, an estimated $17.4K.
  • Quadrant Capital Group first reported a position in Wave Life Sciences in Q2 2021 and held it in 9 quarters.
  • Quadrant Capital Group's Wave Life Sciences position peaked at $40.7K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.